Myocardial cardiomyopathy disease

Citations 1-10 of 67 total displayed.

Most recent content (1 Dec 2009):

Original Articles
Prorenin Contributes to Angiotensin Peptide Formation in Transgenic Rats With Rat Prorenin Expression Targeted to the Liver

Duncan J. Campbell, Habib Karam, Joël Ménard, Patrick Bruneval, and John J. Mullins
Hypertension 2009;54:1248-1253; published online before print as doi:10.1161/HYPERTENSIONAHA.109.138495 [Abstract] [Full text]  

Past content (since Jan 2000):

Scientific Contributions
Prorenin Contributes to Angiotensin Peptide Formation in Transgenic Rats With Rat Prorenin Expression Targeted to the Liver

Duncan J. Campbell, Habib Karam, Joël Ménard, Patrick Bruneval, and John J. Mullins
Hypertension published October 19, 2009, doi:10.1161/HYPERTENSIONAHA.109.138495 [Abstract]  

Editorial Commentaries
Have No Fear, MitoQ₁₀ Is Here

John C. Barbato
Hypertension 2009;54:222-223; published online before print as doi:10.1161/HYPERTENSIONAHA.109.135533 [Full text]  

Editorial Commentary
Have No Fear, MitoQ₁₀ Is Here

John C. Barbato
Hypertension published July 6, 2009, doi:10.1161/HYPERTENSIONAHA.109.135533 [Abstract]  

Original Articles
Metallothionein Abrogates GTP Cyclohydrolase I Inhibition–Induced Cardiac Contractile and Morphological Defects: Role of Mitochondrial Biogenesis

Asli F. Ceylan-Isik, Kelly K. Guo, Edward C. Carlson, Jamie R. Privratsky, Song-Jie Liao, Lu Cai, Alex F. Chen, and Jun Ren
Hypertension 2009;53:1023-1031; published online before print as doi:10.1161/HYPERTENSIONAHA.108.123422 [Abstract] [Full text]  

Scientific Contributions
Metallothionein Abrogates GTP Cyclohydrolase I Inhibition–Induced Cardiac Contractile and Morphological Defects. Role of Mitochondrial Biogenesis

Asli F. Ceylan-Isik, Kelly K. Guo, Edward C. Carlson, Jamie R. Privratsky, Song-Jie Liao, Lu Cai, Alex F. Chen, and Jun Ren
Hypertension published April 27, 2009, doi:10.1161/HYPERTENSIONAHA.108.123422 [Abstract]  

Brief Reviews
Modulation of the Endocannabinoid System in Cardiovascular Disease: Therapeutic Potential and Limitations

Pál Pacher, Partha Mukhopadhyay, Rajesh Mohanraj, Grzegorz Godlewski, Sándor Bátkai, and George Kunos
Hypertension 2008;52:601-607; published online before print as doi:10.1161/HYPERTENSIONAHA.105.063651 [Full text]  

Brief Reviews
Modulation of the Endocannabinoid System in Cardiovascular Disease. Therapeutic Potential and Limitations

Pál Pacher, Partha Mukhopadhyay, Rajesh Mohanraj, Grzegorz Godlewski, Sándor Bátkai, and George Kunos
Hypertension published September 8, 2008, doi:10.1161/HYPERTENSIONAHA.105.063651 [Abstract]  

Original Articles
Pharmacological Inhibition of -Protein Kinase C Attenuates Cardiac Fibrosis and Dysfunction in Hypertension-Induced Heart Failure

Koichi Inagaki, Tomoyoshi Koyanagi, Natalia C. Berry, Lihan Sun, and Daria Mochly-Rosen
Hypertension 2008;51:1565-1569; published online before print as doi:10.1161/HYPERTENSIONAHA.107.109637 [Abstract] [Full text]  

Scientific Contributions
Pharmacological Inhibition of -Protein Kinase C Attenuates Cardiac Fibrosis and Dysfunction in Hypertension-Induced Heart Failure

Koichi Inagaki, Tomoyoshi Koyanagi, Natalia C. Berry, Lihan Sun, and Daria Mochly-Rosen
Hypertension published April 14, 2008, doi:10.1161/HYPERTENSIONAHA.107.109637 [Abstract]  

[Next page] Pages: 1 2 3 4 5 6 7